IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.
Dwyer G.K., Mathews L.R., Villegas J.A., Lucas A., Gonzalez de Peredo A., Blazar B.R., Girard J.P., Poholek A.C., Luther S.A., Shlomchik W. et al., 2022/06/15. Journal of clinical investigation, 132 (12) pp. e150927. Peer-reviewed.
ici le détail